Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture

Approximately 10,000 cases of tick-borne encephalitis (TBE), a serious disease of the central nervous system caused by tick-borne encephalitis virus (TBEV), are registered worldwide every year. Vaccination against TBE remains the most essential measure of preventing the disease. Unlike available TBE...

Descripción completa

Detalles Bibliográficos
Autores principales: Vorovitch, Mikhail F., Grishina, Karina G., Volok, Viktor P., Chernokhaeva, Liubov L., Grishin, Konstantin V., Karganova, Galina G., Ishmukhametov, Aidar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553679/
https://www.ncbi.nlm.nih.gov/pubmed/32429733
http://dx.doi.org/10.1080/21645515.2020.1757990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553679/
https://www.ncbi.nlm.nih.gov/pubmed/32429733
http://dx.doi.org/10.1080/21645515.2020.1757990

Ejemplares similares